Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Rossella Stella
Observed name:
R. Stella
Institution:
Azienda sanitaria universitaria Giuliano Isontina
Observed institutions:
University of Udine,
Azienda sanitaria universitaria Friuli Centrale,
Azienda sanitaria universitaria Giuliano Isontina
ORCID:
0000-0003-0565-150X
Observed ORCID:
0000-0003-0565-150X
OpenAlex ID:
A5039909524
Ruxolitinib discontinuation syndrome: incidence, risk factors, and management in 251 patients with myelofibrosis
2021
·
Francesca Palandri
, Giuseppe Alberto Palumbo
, et al.
·
Blood Cancer Journal
·
88
PDF
Second primary malignancy in myelofibrosis patients treated with ruxolitinib
2020
·
Nicola Polverelli
, Elena M. Elli
, et al.
·
British Journal of Haematology
·
45
Cytomegalovirus Prophylaxis versus Pre-emptive Strategy: Different CD4+ and CD8+ T Cell Reconstitution after Allogeneic Hematopoietic Stem Cell Transplantation
2021
·
Alessandra Sperotto
, Anna Candoni
, et al.
·
Transplantation and Cellular Therapy
·
32
Ruxolitinib rechallenge in resistant or intolerant patients with myelofibrosis: Frequency, therapeutic effects, and impact on outcome
2021
·
Francesca Palandri
, Mario Tiribelli
, et al.
·
Cancer
·
26
PDF
Low-density lipoprotein (LDL) levels and risk of arterial occlusive events in chronic myeloid leukemia patients treated with nilotinib
2021
·
Giovanni Caocci
, Olga Mulas
, et al.
·
Annals of Hematology
·
20
Renin angiotensin system inhibitors reduce the incidence of arterial thrombotic events in patients with hypertension and chronic myeloid leukemia treated with second- or third-generation tyrosine kinase inhibitors
2020
·
Olga Mulas
, Giovanni Caocci
, et al.
·
Annals of Hematology
·
14
PDF
Risk Factors and Outcome of C. difficile Infection after Hematopoietic Stem Cell Transplantation
2020
·
Chiara Rosignoli
, Giuseppe Petruzzellis
, et al.
·
Journal of Clinical Medicine
·
12
PDF
Low low-density lipoprotein (LDL), cholesterol and triglycerides plasma levels are associated with reduced risk of arterial occlusive events in chronic myeloid leukemia patients treated with ponatinib in the real-life. A Campus CML study
2020
·
Giovanni Caocci
, Olga Mulas
, et al.
·
Blood Cancer Journal
·
12
PDF
BCR::ABL1 levels at first month after TKI discontinuation predict subsequent maintenance of treatment‐free remission: A study from the “GRUPPO TRIVENETO LMC”
2022
·
Sara Di Giusto
, Eleonora Toffoletti
, et al.
·
Cancer Medicine
·
10
PDF
Differential Treatment Strategy in Polycythemia Vera Patients with Stable Suboptimal Response to Hydroxyurea: Clinical Correlations and Impact on Survival
2020
·
Francesca Palandri
, Daniela Bartoletti
, et al.
·
Blood
·
4
Ropeginterferon alfa-2b in 248 patients with polycythemia vera: Results from the italian cohort of a prospective, non-interventional, post-authorization study (ROPEG-PV)
2025
·
Tiziano Barbui
, Arianna Ghirardi
, et al.
·
Blood
·
1
PDF
High JAK2V617F allele burden in low-risk PV: an additional recommendation to start “early” cytoreduction? Results from a multicentric study
2025
·
Luca Tosoni
, Sara Di Giusto
, et al.
·
Leukemia Research
·
1
Ruxolitinib Rechallenge in Resistant/Intolerant MF Patients: Frequency, Therapeutic Effects, and Impact on Outcome
2020
·
Francesca Palandri
, Mario Tiribelli
, et al.
·
Blood
·
1
BCR-ABL1 Levels at First Month after TKI Discontinuation Predict Subsequent Maintenance of Treatment-Free Remission: A Study from the "Gruppo Triveneto LMC"
2020
·
Sara Di Giusto
, Eleonora Toffoletti
, et al.
·
Blood
·
1
Generic Versus Branded Imatinib As Frontline Therapy in Chronic-Phase Chronic Myeloid Leukemia Patients in Italy: A Case-Control Study
2019
·
Massimiliano Bonifacio
, Mario Tiribelli
, et al.
·
Blood
·
1
First Line Treatment with Hydroxyurea in Patients with Policitemia Vera: Evaluation of Efficacy in the Current Clinical Practice Beyond ELN Criteria
2020
·
Roberto Latagliata
, Massimo Breccia
, et al.
·
Blood
Low Cholesterol, Low-Density Lipoprotein (LDL) and Triglycerides Plasma Levels Are Associated with Lower Risk of Arterial Occlusive Events in Chronic Myeloid Leukemia Patients Treated with Nilotinib
2020
·
Giovanni Caocci
, Olga Mulas
, et al.
·
Blood
Pb1930 Correlation Between Levels of Early Molecular Response and Bcr-abl Transcript Type in Stable Dmr Attainment in Cml Patients Treated With Imatinib
2019
·
M. Tiribelli
, M. Bonifacio
, et al.
·
HemaSphere
Show more works
View as search
Works count:
18
Citation count:
268
H-index:
9
I10-index:
9
Year
Topic
Type